Skip to Main content Skip to Navigation
Journal articles

Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy

Abstract : Sepsis, or systemic inflammatory response syndrome, is the major cause of critical illness resulting in admission to intensive care units. Sepsis is caused by severe infection and is associated with mortality in 60% of cases. Morbidity due to sepsis is complicated by neuromyopathy, and patients face long-term disability due to muscle weakness, energetic dysfunction, proteolysis and muscle wasting. These processes are triggered by pro-inflammatory cytokines and metabolic imbalances and are aggravated by malnutrition and drugs. Skeletal muscle regeneration depends on stem (satellite) cells. Herein we show that mitochondrial and metabolic alterations underlie the sepsis-induced long-term impairment of satellite cells and lead to inefficient muscle regeneration. Engrafting mesenchymal stem cells improves the septic status by decreasing cytokine levels, restoring mitochondrial and metabolic function in satellite cells, and improving muscle strength. These findings indicate that sepsis affects quiescent muscle stem cells and that mesenchymal stem cells might act as a preventive therapeutic approach for sepsis-related morbidity.
Document type :
Journal articles
Complete list of metadatas

Cited literature [51 references]  Display  Hide  Download

https://hal-pasteur.archives-ouvertes.fr/pasteur-01246546
Contributor : Pierre Rocheteau <>
Submitted on : Friday, December 18, 2015 - 4:40:53 PM
Last modification on : Tuesday, October 20, 2020 - 11:02:40 AM
Long-term archiving on: : Saturday, April 29, 2017 - 10:00:26 PM

File

ncomms10145.pdf
Publication funded by an institution

Licence


Distributed under a Creative Commons Attribution 4.0 International License

Identifiers

Citation

Pierre Rocheteau, Laurent Chatre, David Briand, M Mebarki, Grégory Jouvion, et al.. Sepsis induces long-term metabolic and mitochondrial muscle stem cell dysfunction amenable by mesenchymal stem cell therapy. Nature Communications, Nature Publishing Group, 2015, ⟨10.1038/ncomms10145⟩. ⟨pasteur-01246546⟩

Share

Metrics

Record views

2219

Files downloads

1329